388 related articles for article (PubMed ID: 17234541)
21. CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma.
Chen S; Caragine T; Cheung NK; Tomlinson S
Cancer Res; 2000 Jun; 60(11):3013-8. PubMed ID: 10850450
[TBL] [Abstract][Full Text] [Related]
22. Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis.
Uesu T; Mizuno M; Inoue H; Tomoda J; Tsuji T
Lab Invest; 1995 May; 72(5):587-91. PubMed ID: 7538183
[TBL] [Abstract][Full Text] [Related]
23. Effect of periodontopathogen lipopolysaccharides and proinflammatory cytokines on CD46, CD55, and CD59 gene/protein expression by oral epithelial cells.
Mahtout H; Curt S; Chandad F; Rouabhia M; Grenier D
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):295-303. PubMed ID: 21545652
[TBL] [Abstract][Full Text] [Related]
24. Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue.
Murray KP; Mathure S; Kaul R; Khan S; Carson LF; Twiggs LB; Martens MG; Kaul A
Gynecol Oncol; 2000 Feb; 76(2):176-82. PubMed ID: 10637067
[TBL] [Abstract][Full Text] [Related]
25. Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma.
Macor P; Mezzanzanica D; Cossetti C; Alberti P; Figini M; Canevari S; Tedesco F
Cancer Res; 2006 Apr; 66(7):3876-83. PubMed ID: 16585216
[TBL] [Abstract][Full Text] [Related]
26. Membrane-bound complement regulatory proteins are prognostic factors of operable breast cancer treated with adjuvant trastuzumab: a retrospective study.
Liu M; Yang YJ; Zheng H; Zhong XR; Wang Y; Wang Z; Wang YG; Wang YP
Oncol Rep; 2014 Dec; 32(6):2619-27. PubMed ID: 25241923
[TBL] [Abstract][Full Text] [Related]
27. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59.
Clayton A; Harris CL; Court J; Mason MD; Morgan BP
Eur J Immunol; 2003 Feb; 33(2):522-31. PubMed ID: 12645951
[TBL] [Abstract][Full Text] [Related]
28. Complement regulatory proteins in the salivary glands and saliva of Sjögren's syndrome patients and healthy subjects.
Cuida M; Legler DW; Eidsheim M; Jonsson R
Clin Exp Rheumatol; 1997; 15(6):615-23. PubMed ID: 9444417
[TBL] [Abstract][Full Text] [Related]
29. Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A.
Juhl H; Helmig F; Baltzer K; Kalthoff H; Henne-Bruns D; Kremer B
J Surg Oncol; 1997 Mar; 64(3):222-30. PubMed ID: 9121154
[TBL] [Abstract][Full Text] [Related]
30. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
[TBL] [Abstract][Full Text] [Related]
31. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV).
Spear GT; Lurain NS; Parker CJ; Ghassemi M; Payne GH; Saifuddin M
J Immunol; 1995 Nov; 155(9):4376-81. PubMed ID: 7594597
[TBL] [Abstract][Full Text] [Related]
32. CD55 limits sensitivity to complement-dependent cytolysis triggered by heterologous expression of α-gal xenoantigen in colon tumor cells.
Wu Y; Wang Y; Qin F; Wang Z; Wang Y; Yang Y; Zheng H; Wang Y
Am J Physiol Gastrointest Liver Physiol; 2014 Jun; 306(12):G1056-64. PubMed ID: 24763553
[TBL] [Abstract][Full Text] [Related]
33. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction.
Saifuddin M; Hedayati T; Atkinson JP; Holguin MH; Parker CJ; Spear GT
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1907-11. PubMed ID: 9266986
[TBL] [Abstract][Full Text] [Related]
34. The complement regulatory proteins CD46 and CD59, but not CD55, are highly expressed by glandular epithelium of human breast and colorectal tumour tissues.
Thorsteinsson L; O'Dowd GM; Harrington PM; Johnson PM
APMIS; 1998 Sep; 106(9):869-78. PubMed ID: 9808413
[TBL] [Abstract][Full Text] [Related]
35. Expression of GPI-anchored complement regulatory proteins CD55 and CD59 differentiates two subpopulations of human CD56+ CD3- lymphocytes (NK cells).
Solomon KR; Chan M; Finberg RW
Cell Immunol; 1995 Oct; 165(2):294-301. PubMed ID: 7553895
[TBL] [Abstract][Full Text] [Related]
36. Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma.
Weng WK; Levy R
Blood; 2001 Sep; 98(5):1352-7. PubMed ID: 11520782
[TBL] [Abstract][Full Text] [Related]
37. Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections.
Nuutila J; Jalava-Karvinen P; Hohenthal U; Kotilainen P; Pelliniemi TT; Nikoskelainen J; Lilius EM
Hum Immunol; 2013 May; 74(5):522-30. PubMed ID: 23376460
[TBL] [Abstract][Full Text] [Related]
38. Cytokines modulate expression of cell-membrane complement inhibitory proteins in human lung cancer cell lines.
Varsano S; Rashkovsky L; Shapiro H; Radnay J
Am J Respir Cell Mol Biol; 1998 Sep; 19(3):522-9. PubMed ID: 9730881
[TBL] [Abstract][Full Text] [Related]
39. Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapy.
Bjørge L; Stoiber H; Dierich MP; Meri S
Scand J Immunol; 2006 May; 63(5):355-64. PubMed ID: 16640659
[TBL] [Abstract][Full Text] [Related]
40. Coordinate functions of multiple complement regulating molecules, CD46, CD55, and CD59.
Loveland BE; Szokolai K; Johnstone RW; McKenzie IF
Transplant Proc; 1994 Jun; 26(3):1070-1. PubMed ID: 7518104
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]